274 related articles for article (PubMed ID: 36660642)
1. Analysis of C-X-C motif chemokine receptors in breast cancer: potential value in immunotherapy and prognostic prediction.
Sun Y; Yang M; Zhang Q
Ann Transl Med; 2022 Dec; 10(24):1379. PubMed ID: 36660642
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Value and Therapeutic Perspectives of CXCR Members in the Glioma Microenvironment.
He J; Jiang Z; Lei J; Zhou W; Cui Y; Luo B; Zhang M
Front Genet; 2022; 13():787141. PubMed ID: 35571062
[No Abstract] [Full Text] [Related]
3. Multi-omics analysis revealing a senescence-relevant lncRNAs signature for the assessment of response to immunotherapy for breast cancer.
Yu Z; Zhu Y; Ji J
Medicine (Baltimore); 2023 Jul; 102(28):e34287. PubMed ID: 37443486
[TBL] [Abstract][Full Text] [Related]
4. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
Front Immunol; 2022; 13():947802. PubMed ID: 36405735
[TBL] [Abstract][Full Text] [Related]
5. Development of a circHIPK3-based ceRNA network and identification of mRNA signature in breast cancer patients harboring BRCA mutation.
Lian QX; Song Y; Han L; Wang Z; Song Y
PeerJ; 2023; 11():e15572. PubMed ID: 37426414
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of CXCR family members in lung adenocarcinoma with prognostic values.
Hu LT; Deng WJ; Chu ZS; Sun L; Zhang CB; Lu SZ; Weng JR; Ren QS; Dong XY; Li WD; Li XB; Du YT; Li Y; Wang WQ
BMC Pulm Med; 2022 Jun; 22(1):259. PubMed ID: 35768814
[TBL] [Abstract][Full Text] [Related]
7. Immunological Value of Prognostic Signature Based on Cancer Stem Cell Characteristics in Hepatocellular Carcinoma.
Xu Q; Xu H; Chen S; Huang W
Front Cell Dev Biol; 2021; 9():710207. PubMed ID: 34409040
[No Abstract] [Full Text] [Related]
8. Polo-like kinase 1 as a biomarker predicts the prognosis and immunotherapy of breast invasive carcinoma patients.
Shen J; Zhang W; Jin Q; Gong F; Zhang H; Xu H; Li J; Yao H; Jiang X; Yang Y; Hong L; Mei J; Song Y; Zhou S
Oncol Res; 2023; 32(2):339-351. PubMed ID: 38186570
[TBL] [Abstract][Full Text] [Related]
9. A seven-nuclear receptor-based prognostic signature in breast cancer.
Wu F; Chen W; Kang X; Jin L; Bai J; Zhang H; Zhang X
Clin Transl Oncol; 2021 Jul; 23(7):1292-1303. PubMed ID: 33210236
[TBL] [Abstract][Full Text] [Related]
10. KIF2C is a prognostic biomarker associated with immune cell infiltration in breast cancer.
Liu S; Ye Z; Xue VW; Sun Q; Li H; Lu D
BMC Cancer; 2023 Apr; 23(1):307. PubMed ID: 37016301
[TBL] [Abstract][Full Text] [Related]
11. Construction of a breast cancer prognosis model based on alternative splicing and immune infiltration.
Zhang D; Lu W; Zhuo Z; Mei H; Wu X; Cui Y
Discov Oncol; 2022 Aug; 13(1):78. PubMed ID: 35988113
[TBL] [Abstract][Full Text] [Related]
12. A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.
Xu HH; Wang HL; Xing TJ; Wang XQ
Front Immunol; 2022; 13():851622. PubMed ID: 35924232
[TBL] [Abstract][Full Text] [Related]
13. Identification and validation of a novel zinc finger protein-related gene-based prognostic model for breast cancer.
Ye M; Li L; Liu D; Wang Q; Zhang Y; Zhang J
PeerJ; 2021; 9():e12276. PubMed ID: 34721975
[TBL] [Abstract][Full Text] [Related]
14. Identification of a tumor immune-inflammation signature predicting prognosis and immune status in breast cancer.
Liu Y; Ouyang W; Huang H; Tan Y; Zhang Z; Yu Y; Yao H
Front Oncol; 2022; 12():960579. PubMed ID: 36713514
[TBL] [Abstract][Full Text] [Related]
15. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
[TBL] [Abstract][Full Text] [Related]
16. Development and Validation of CXCR4 Nomogram-Based Immune Infiltration/Tumor Inflammation in Primary Glioblastoma.
Jiang G; Zheng ZQ; Zhang J; Tian Z; Li X; Yu Z; Wang Z; You W; Chen G
Brain Sci; 2023 Aug; 13(8):. PubMed ID: 37626511
[TBL] [Abstract][Full Text] [Related]
17. Establishment of a N1-methyladenosine-related risk signature for breast carcinoma by bioinformatics analysis and experimental validation.
Li L; Yang W; Jia D; Zheng S; Gao Y; Wang G
Breast Cancer; 2023 Jul; 30(4):666-684. PubMed ID: 37178414
[TBL] [Abstract][Full Text] [Related]
18. Establishment and validation of an aging-related risk signature associated with prognosis and tumor immune microenvironment in breast cancer.
Wang Z; Liu H; Gong Y; Cheng Y
Eur J Med Res; 2022 Dec; 27(1):317. PubMed ID: 36581948
[TBL] [Abstract][Full Text] [Related]
19. Expression profile and prognostic value of CXCR family members in head and neck squamous cell carcinoma.
Shen Y; Zhou C; Cao Y; Li Q; Deng H; Gu S; Wu Y; Shen Z
World J Surg Oncol; 2022 Aug; 20(1):259. PubMed ID: 35978426
[TBL] [Abstract][Full Text] [Related]
20. Identification and validation of a five-gene prognostic signature based on bioinformatics analyses in breast cancer.
Du XJ; Yang XR; Wang QC; Lin GL; Li PF; Zhang WF
Heliyon; 2023 Feb; 9(2):e13185. PubMed ID: 36747547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]